Bayer AG Stock price

Equities

BAYN

DE000BAY0017

Pharmaceuticals

Real-time Estimate Tradegate 07:30:10 2024-03-19 am EDT 5-day change 1st Jan Change
25.77 EUR -1.69% Intraday chart for Bayer AG -2.60% -23.28%
Sales 2024 * 47.31B 51.31B Sales 2025 * 48.53B 52.63B Capitalization 25.75B 27.93B
Net income 2024 * 2.26B 2.45B Net income 2025 * 3.63B 3.94B EV / Sales 2024 * 1.24 x
Net Debt 2024 * 32.98B 35.77B Net Debt 2025 * 29.8B 32.32B EV / Sales 2025 * 1.14 x
P/E ratio 2024 *
12.1 x
P/E ratio 2025 *
7.35 x
Employees 96,931
Yield 2024 *
0.71%
Yield 2025 *
3.07%
Free-Float 99.97%
More Fundamentals * Assessed data
Dynamic Chart
1 day-1.40%
1 week-2.57%
Current month-8.12%
1 month-10.69%
3 months-19.83%
6 months-47.25%
Current year-23.25%
More quotes
1 week
25.74
Extreme 25.74
26.59
1 month
24.96
Extreme 24.96
29.35
Current year
24.96
Extreme 24.96
36.09
1 year
24.96
Extreme 24.96
61.91
3 years
24.96
Extreme 24.96
67.99
5 years
24.96
Extreme 24.96
78.34
10 years
24.96
Extreme 24.96
146.45
More quotes
Managers TitleAgeSince
Chief Executive Officer 57 23-03-31
Director of Finance/CFO 54 18-04-25
Chief Tech/Sci/R&D Officer 55 20-03-31
Members of the board TitleAgeSince
Director/Board Member 68 17-03-31
Director/Board Member 68 17-03-31
Director/Board Member 68 21-03-31
More insiders
Date Price Change Volume
24-03-19 25.79 -1.62% 1 435 263
24-03-18 26.22 -0.08% 2,958,874
24-03-15 26.24 +0.81% 9,539,161
24-03-14 26.02 -1.27% 3,608,300
24-03-13 26.36 -0.49% 3,351,866

Delayed Quote Xetra, March 19, 2024 at 06:41 am EDT

More quotes
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (49.6%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (37.9%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12%); - other (0.5%). Net sales are distributed geographically as follows: Germany (4.9%), Switzerland (1.2%), Europe/Middle East/Africa (22.4%), the United States (30.9%), North America (3.7%), China (8.4%), Asia/Pacific (10.2%), Brazil (10.5%) and Latin America (7.8%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
21
Last Close Price
26.22 EUR
Average target price
38.38 EUR
Spread / Average Target
+46.41%
Consensus
  1. Stock
  2. Equities
  3. Stock Bayer AG - Xetra